|
Volumn 18, Issue 5, 2007, Pages 291-294
|
Methotrexate-betamethasone weekly oral pulse in psoriasis
|
Author keywords
Betamethasone; Methotrexate; Methotrexate betamethasone weekly pulse; Prolonged remission; Psoriasis; Pulse therapy
|
Indexed keywords
ALANINE AMINOTRANSFERASE;
ALKALINE PHOSPHATASE;
ASPARTATE AMINOTRANSFERASE;
BETAMETHASONE;
CORTICOSTEROID;
METHOTREXATE;
ADULT;
ALANINE AMINOTRANSFERASE BLOOD LEVEL;
ALKALINE PHOSPHATASE BLOOD LEVEL;
ARTICLE;
ASPARTATE AMINOTRANSFERASE BLOOD LEVEL;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DISEASE DURATION;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
FOLLOW UP;
HUMAN;
MALE;
PRIORITY JOURNAL;
PSORIASIS;
PSORIASIS SEVERITY INDEX;
REMISSION;
SCORING SYSTEM;
SIDE EFFECT;
TREATMENT OUTCOME;
ADMINISTRATION, ORAL;
ADOLESCENT;
ADULT;
BETAMETHASONE;
DERMATOLOGIC AGENTS;
DRUG ADMINISTRATION SCHEDULE;
DRUG THERAPY, COMBINATION;
FEMALE;
GLUCOCORTICOIDS;
HUMANS;
MALE;
METHOTREXATE;
MIDDLE AGED;
PSORIASIS;
RECURRENCE;
SEVERITY OF ILLNESS INDEX;
TREATMENT OUTCOME;
|
EID: 35148839119
PISSN: 09546634
EISSN: 14711753
Source Type: Journal
DOI: 10.1080/09546630701487643 Document Type: Article |
Times cited : (20)
|
References (13)
|